The Hematocrit Affects the Volume of Plasma Treated With Coupled Plasma Filtration and Adsorption With Predilution.
Stefano FinazziElena GarberoGiampietro TrussardiGuido BertoliniPublished in: Artificial organs (2017)
Coupled plasma filtration and adsorption (CPFA) is an extracorporeal blood purification technique proposed for the treatment of septic-shock. By removing pro- and anti-inflammatory mediators from plasma, CPFA is supposed to have a therapeutic effect on the abnormal inflammatory response seen in this condition. Recently, blood predilution with citrate solution has been adopted to prevent clotting in the CPFA circuit-one of the main problems of the technique. Taking into account the patient's hematocrit, we worked out a formula for the volume of plasma effectively treated by CPFA after predilution. Neglecting this effect, as is commonly done, introduces significant distortions in the estimation of the volume, possibly causing under-treatment. The distortion is stronger when the hematocrit and the predilution fraction are large and weaker when both values shrink. By correctly indicating the daily dose of plasma adsorption received by patients, this formula is essential for assessing the therapeutic efficacy of CPFA and, subsequently, establishing its optimal doses.
Keyphrases
- inflammatory response
- anti inflammatory
- end stage renal disease
- septic shock
- newly diagnosed
- mental health
- chronic kidney disease
- physical activity
- prognostic factors
- lipopolysaccharide induced
- human milk
- combination therapy
- aqueous solution
- lps induced
- preterm birth
- replacement therapy
- patient reported
- patient reported outcomes
- low birth weight